Attached files
| file | filename |
|---|---|
| EX-10.1 - EXHIBIT 10.1 FORM OF SECURITIES PURCHASE AGREEMENT - TRxADE HEALTH, INC | f8k111318_ex10z1.htm |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report: November 14, 2018
Date of Earliest Event Reported: November 13, 2018
000-55218 |
(Commission file number) |
Trxade Group, Inc. |
(Exact name of registrant as specified in its charter) |
Delaware |
| 46-3673928 |
(State or other jurisdiction of incorporation or organization) |
| (IRS Employer Identification No.) |
3840 Land O’ Lakes Blvd |
Land O’ Lakes, Florida |
34639 |
(Address of principal executive offices) |
|
800-261-0281 |
(Issuer’s telephone number) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01. Entry into a Material Definitive Agreement.
On November 13, 2018, Trxade Group, Inc. (the “Company”) entered into a Securities Purchase Agreement with an accredited investor with respect to the private placement of 1,000,000 shares of its common stock at a purchase price of $0.50 per share, for gross proceeds of approximately $500,000.
The foregoing is a summary of the material provisions of the Securities Purchase Agreement. This summary is not intended to be complete and is qualified in its entirety by reference to the full text of the Securities Purchase Agreement, filed as Exhibits 10.1 to this Current Report, and which is incorporated into this Current Report by reference
Item 3.02. Unregistered Sales of Equity Securities
The issuances of the common stock described above was exempt from registration pursuant to Section 4(2), Rule 506 of Regulation D and/or Regulation S of the Securities Act since the foregoing issuances and grants did not involve a public offering, the recipients took the securities for investment and not resale, we took take appropriate measures to restrict transfer, and the recipients were (a) “accredited investors”; (b) had access to similar documentation and information as would be required in a Registration Statement under the Act; (c) were non-U.S. persons; and/or (d) were officers or directors of the Company.
Item 9.01. Financial Statements and Exhibits.
Exhibit No.Exhibit Description
10.1Form of Securities Purchase Agreement
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Trxade Group, Inc.
By:/s/ Suren Ajjarapu
Suren Ajjarapu, Chief Executive Officer
Date: November 14, 2018